恆星科技(002132.SZ):年產12萬噸高性能有機硅聚合物項目達到試生產條件
格隆匯12月29日丨恆星科技(002132.SZ)公佈,公司控股子公司內蒙古恆星化學有限公司(以下簡稱“恆星化學”)“年產12萬噸高性能有機硅聚合物項目”試生產方案獲專家組評審通過,具備投料試車條件,可正式進入試生產階段。
“年產12萬噸高性能有機硅聚合物項目”的投產有利於提升公司的盈利能力,將對公司未來的經營業績產生積極影響,但項目從試生產階段到全面達產尚需一定的時間,亦有可能面臨市場價格波動、競爭加劇等不確定因素的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.